www.fdanews.com/articles/69247-cti-molecular-imaging-announces-dismissal-of-lawsuit
CTI Molecular Imaging Announces Dismissal of Lawsuit
February 28, 2005
CTI Molecular Imaging, a provider of positron emission
tomography (PET) equipment, molecular probes and services, announced that the
U.S. District Court for the Eastern District of Tennessee recently issued an
order granting summary judgment in favor of the company and CTI PET Systems
(which does business as CPS Innovations) as defendants in a patent infringement
case brought by the Board of Regents, The University of Texas System and M.D.
Anderson Cancer Center v. CTI Molecular Imaging, CTI and CTI PET Systems.
PR
Newswire